Filter
738
Text search:
oxygen
therapy
Featured
Recommendations
144
New Publications
146
Language
Document type
No document type
341
Guidelines
206
Studies & Reports
68
Manuals
60
Fact sheets
15
Infographics
12
Strategic & Response Plan
12
Training Material
11
Online Courses
4
Situation Updates
3
Brochures
2
Resource Platforms
2
Videos
2
Countries / Regions
India
72
Kenya
27
Global
23
South Africa
22
Rwanda
20
Ethiopia
14
Tanzania
14
Nigeria
13
Zambia
13
Liberia
12
Uganda
12
Nepal
12
Russia
11
Bangladesh
10
Latin America and the Carribbean
9
Philippines
8
Namibia
8
Africa
8
Sierra Leone
7
Ghana
7
Syria
7
Indonesia
7
Malawi
7
Western and Central Europe
7
Brazil
6
Ukraine
5
Eswatini/ Swaziland
4
Zimbabwe
3
Haiti
3
Somalia
3
South Sudan
3
Germany
3
Myanmar / Burma
3
West and Central Africa
3
Middle East and North Africa
3
South–East Asia Region
3
Eastern Europe and Central Asia
3
Senegal
2
USA
2
Cambodia
2
Mozambique
2
Angola
2
Yemen
2
East and Southern Africa
2
Asia
2
Eastern Europe
2
Vietnam
2
United Kingdom
2
Congo, Democratic Republic of
1
Guinea-Bissau
1
Saudi Arabia
1
Cameroon
1
Iraq
1
Afghanistan
1
Turkey
1
Chad
1
Gambia
1
China
1
Papua New Guinea
1
Argentina
1
North Macedonia
1
Hungary
1
Botswana
1
Libya
1
Lesotho
1
Other region
1
Fiji
1
Solomon Islands
1
Poland
1
Timor Leste/ East Timor
1
Bulgaria
1
Romania
1
Moldova
1
Slovakia
1
France
1
Portugal
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
324
Clinical Guidelines
120
Women & Child Health
74
Public Health
36
Capacity Building
11
Key Resources
11
Pharmacy & Technologies
9
Protection & Security
1
Toolboxes
COVID-19
149
Caregiver
52
NCDs
33
Mental Health
27
Pharmacy
25
TB
24
Rapid Response
23
Ebola
17
NTDs
16
Disability
15
Conflict
15
HIV
12
AMR
9
Specific Hazards
7
Planetary Health
6
Cholera
4
Refugee
4
Health Financing Toolbox
4
Global Health Education
3
Natural Hazards
2
Polio
1
Zika
1
Pathogens . 2021 Nov 16;10(11):1493.doi: 10.3390/pathogens10111493
.Chronic manifestations of Chagas disease present as disabling and life-threatening condi-tions affecting mainly the cardiovascular and gastrointestinal systems. Although meaningful research has outlined the different molecular mech
...
Front Chem. 2021; 9: 622286.
Published online 2021 Mar 12. doi: 10.3389/fchem.2021.622286
Nearly 260 000 people died in parts of Somalia between October 2010 and April 2012, including
133 000 children under five during the famine and food crisis in Somalia making it the worst famine in history.
A study commissioned and funded by the Food and Agriculture Organization of the United Natio
...
During the 17 years since Surgical approaches to the urogenital manifestations of lymphatic filariasis was first published, there has been heightened awareness of the physical, economic and emotional burden of the genitourinary manifestations of filariasis. With the impetus to provide better guidanc
...
This bulletin focuses on the situation in Ukraine and several key refugee-receiving countries (Bulgaria, Czechia, Hungary, Poland, Republic of Moldova, Romania, and Slovakia), with the understanding that other countries in the European Region are also receiving Ukrainian refugees and WHO is pr
...
This document puts forward the joint position and vision of an expert, global, multistakeholder working group on implementing Kangaroo Mother Care (KMC) for all preterm or low birth weight (LBW) infants as the foundation for small and/or sick newborn care within maternal, newborn, and child health p
...
The Regional Action Framework for Noncommunicable Disease Prevention and Control provides a unified vision of objectives and recommended actions to combat the noncommunicable disease (NCD) epidemic in the Western Pacific Region. Implementation should be supported by cross-sectoral coordination
...
COVID-19 has altered health sector capacity in low-income and middle-income countries (LMICs). Cost data to inform evidence-based priority setting are urgently needed. Consequently, in this paper, we calculate the full economic health sector costs of COVID-19 clinical management in 79 LMICs under di
...
This results report for the biennium 2020–2021 presents the progress towards the triple billion targets, outcomes and outputs, based on the GPW 13 results framework and indicators. It uses structured methodologies, both quantitative and qualitative, for measuring and analysing the achievements and
...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o
...
Many features of the environment have been found to exert an important influence on cardiovascular disease (CVD) risk, progression, and severity. Changes in the environment due to migration to different geographic locations, modifications in lifestyle choices, and shifts in social policies and cultu
...
Hypertension is referred to as a “silent killer”. Most people with hypertension are unaware of their condition as in most cases, they experience no warning signs or symptoms hence they are not identified or treated. Hypertention is associated with a number of conditions, disability, and causes o
...
Atherosclerotic lower-extremity peripheral artery disease (PAD) is increasingly recognized as an important cause of cardiovascular morbidity and mortality that affects more than 230 million people worldwide. Traditional cardiovascular risk factors, including advanced age, smoking, and diabetes, are
...
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen
...
The incidence and mortality of cardiovascular diseases (CVDs) in low and middle income countries (LMICs) have been increasing, while access to CVDs medicines is suboptimal. We assessed selection of essential medicines for the prevention and treatment of CVDs on national essential medicines lists (NE
...
The Infection Prevention and Control (IPC) Guidelines aim to support healthcare workers improve quality and safety health care. The Guidelines further aim to promote and facilitate the overall goal of IPC by providing evidence-based recommendations on the critical aspects of IPC, focusing on the fun
...
In this document, the Inter-American Committee of Cardiovascular Prevention and Rehabilitation, together with the South
American Society of Cardiology, aimed to formulate strategies, measures, and actions for cardiovascular disease prevention
and rehabilitation (CVDPR). In the context of the imple
...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202
...
Patients with diabetes are at increased risk of developing cardiovascular disease (CVD) with its manifestations of coronary artery disease (CAD), heart failure (HF), atrial fibrillation (AF), and stroke, as well as aortic and peripheral artery diseases. In addition, diabetes is a major risk factor f
...
Cardiovascular diseases (CVDs) are a growing public health problem in Ghana and other African countries. Strokes and other CVDs have become a leading cause of death due to increasing risk factors such as hypertension. According to the Global Burden of Disease study (GBD), ischaemic heart disease was
...
